<DOC>
	<DOCNO>NCT00320034</DOCNO>
	<brief_summary>The commonly use drug immediate relief symptom asthma blue puffer , albuterol salbutamol ( Ventolin ) . Racemic albuterol mixture two form albuterol mirror image i.e . R-and S- isomer . The investigational treatment R-albuterol S-albuterol . R-albuterol ( levalbuterol ) show slightly well bronchodilator effect compare racemic albuterol well- tolerated patient . However still clear whether S-isomer effect harmful effect airway . The purpose study compare effect R- S- isomer allergen induced airway inflammation subject mild atopic asthma . This give u good idea whether routine use levalbuterol superior racemic albuterol .</brief_summary>
	<brief_title>Evaluation Effect Levalbuterol Allergen Induced Airway Inflammation In Subjects With Atopic Asthma</brief_title>
	<detailed_description>The commonly use drug immediate relief symptom asthma blue puffer , albuterol salbutamol ( Ventolin ) . Racemic albuterol mixture two form albuterol mirror image i.e . R-and S- isomer . The investigational treatment R-albuterol S-albuterol . R-albuterol ( levalbuterol ) relieve narrow bronchial air passage lung approve U.S. FDA , currently license use Canada . We obtain approval Health Canada use isomer purpose study . R-albuterol show slightly well bronchodilator effect compare racemic albuterol well- tolerated patient , mild moderate side effect ( palpitation , diarrhoea , abdominal pain , bodyache , leg cramp headache ) . However still clear whether S-isomer effect harmful effect airway . The purpose study determine effect drug , levalbuterol , allergen-induced inflammatory response adult subject asthma . Specifically , want look change airway eosinophils examine sputum sample compare effect R- S- isomer airway inflammation . This help u understand whether racemic albuterol could worsen inflammation presence S-isomer , give u good idea whether routine use levalbuterol superior racemic albuterol .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Male female ( medically surgically postmenopausal practice accepted form barrier hormonal contraception ) subject age 1855 . Stable , mild atopic asthma force expiratory volume one second ( FEV1.0 ) great 70 % predict age height , require medical treatment short act inhaled betaagonists need . No recent significant history cigarette smoking ( cigarette within six month prior entry study ; le 10 packyears cumulative history cigarette smoking ) . Peak decrease FEV1 early ( 02 hour ) late ( 37 hour ) allergenprovoked response &gt; 15 % compare baseline ( preallergen challenge ) spirometric determination . Signed write informed consent participate protocol ; ability return outpatient clinic repeat clinic visit . No history asthma exacerbation acute intercurrent respiratory illness ( viral respiratory syndrome , bronchitis , pneumonia ) six week period precede entry screen phase study . Significant gastrointestinal ( include hepatic ) , hematological , cardiovascular , cerebrovascular body system disorder . History acute exacerbation , respiratory tract infection time past 6 week . Baseline AST ALT ( indicator liver damage ) great twice upper limit normal range local laboratory . History allergy hypersensitivity shortacting betaagonists . Inability discontinue asthma medication duration study receipt oral inhaled corticosteroid leukotriene receptor antagonist three week prior entry screen phase study . Recent ( within past 2 month ) plan ( within study period ) lung volume reduction surgery . Psychosis , alcoholism , active substance abuse , personality disorder would make compliance protocol problematic . Pregnant nursing female . Any medical social condition , opinion investigator , could confound interpretation data derive study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>levalbuterol</keyword>
	<keyword>asthma</keyword>
	<keyword>allergen provocation</keyword>
	<keyword>airway inflammation</keyword>
	<keyword>clinical trial</keyword>
</DOC>